Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Vaxart Stock Is Surging Today

TheMotleyFool

0 0

Shares of Vaxart (NASDAQ: VXRT) climbed on Tuesday after the biotech released promising data from a clinical trial of its oral coronavirus vaccine candidate. As of 3:30 p.m. EDT, Vaxart's stock price was up more than 12%.

A phase 1 study showed Vaxart's vaccine to potentially be protective against COVID-19, as well as a broad array of other coronavirus-induced illnesses, such as SARS, MERS, and the common cold.

Investors bid up Vaxart's share price on Tuesday. Image source: Getty Images.

Source Fool.com

Like: 0

VXRT

Share